Alternate-day dosing of itraconazole in healthy adult cats

S. M. Middleton, A. Kubier, L. Dirikolu, M. G. Papich, M. A. Mitchell, S. I. Rubin

Research output: Contribution to journalArticlepeer-review

Abstract

The current available formulations of itraconazole are not ideal for dosing in cats. The capsular preparation often does not allow for accurate dosing, the oral solution is difficult to administer and poorly tolerated, and the bioavailability of compounded formulations has been shown to be poor in other species. The aim of this study was to evaluate every other day dosing of 100 mg itraconazole capsule in healthy adult cats. Ten healthy adult cats received a 100 mg capsule of itraconazole orally every 48 h for 8 weeks. Peak and trough serum concentrations of itraconazole were measured weekly using high-performance liquid chromatography (HPLC). Physical examination, complete blood count (CBC), and chemistry profiles were performed weekly. The dosage regimen achieved average therapeutic trough concentrations (>0.5 μg/mL) within 3 weeks. The protocol yielded no adverse effects in 8 of the 10 study cats, with affected cats recovering fully with discontinuation of the drug and supportive care. At 8 weeks, an average peak concentration of 1.79 ± 0.952 μg/mL (95% CI: 0.996-2.588) and an average trough concentration of 0.761 ± 0.540 μg/mL (95% CI: 0.314-1.216) were achieved. Overall, a 100 mg every other day oral dosage regimen for itraconazole in cats yielded serum concentrations with minimal fluctuation and with careful monitoring may be considered for treatment of cats with systemic fungal disease.

Original languageEnglish (US)
Pages (from-to)27-31
Number of pages5
JournalJournal of Veterinary Pharmacology and Therapeutics
Volume39
Issue number1
DOIs
StatePublished - Feb 1 2016

ASJC Scopus subject areas

  • Pharmacology
  • veterinary(all)

Fingerprint

Dive into the research topics of 'Alternate-day dosing of itraconazole in healthy adult cats'. Together they form a unique fingerprint.

Cite this